SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-080546
Filing Date
2024-07-02
Accepted
2024-07-02 16:30:11
Documents
11
Period of Report
2024-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K olma-20240628.htm   iXBRL 8-K 39372
  Complete submission text file 0000950170-24-080546.txt   153351

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20240628.xsd EX-101.SCH 24997
13 EXTRACTED XBRL INSTANCE DOCUMENT olma-20240628_htm.xml XML 4749
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 241095988
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)